Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) have received an average recommendation of “Moderate Buy” from the seventeen research firms that are presently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average twelve-month price […]
More Stories
Spartan Delta Corp. (TSE:SDE) Given Average Recommendation of “Buy” by Brokerages
Shares of Spartan Delta Corp. (TSE:SDE – Get Free Report) have been assigned an average recommendation of “Buy” from the...
Mueller Water Products, Inc. (NYSE:MWA) Given Consensus Rating of “Hold” by Brokerages
Shares of Mueller Water Products, Inc. (NYSE:MWA – Get Free Report) have earned a consensus rating of “Hold” from the...
Neurogene Inc. (NASDAQ:NGNE) Receives $51.00 Consensus PT from Analysts
Shares of Neurogene Inc. (NASDAQ:NGNE – Get Free Report) have been given a consensus recommendation of “Buy” by the nine...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Given Average Rating of “Hold” by Brokerages
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) have been given an average recommendation of “Hold” by the...
A.P. Møller – Mærsk A/S (OTCMKTS:AMKBY) Receives Consensus Recommendation of “Reduce” from Brokerages
A.P. Møller – Mærsk A/S (OTCMKTS:AMKBY – Get Free Report) has been assigned an average recommendation of “Reduce” from the...
Middlefield Banc (NASDAQ:MBCN) Upgraded at StockNews.com
StockNews.com upgraded shares of Middlefield Banc (NASDAQ:MBCN – Free Report) from a sell rating to a hold rating in a...